Clinical trial
Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal…
NCT00156975 · Arbeitsgruppe Lebermetastasen und Tumoren, Other · Unknown status
Key facts
| NCT number | NCT00156975 |
|---|---|
| Title | Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases |
| Official title | Adjuvant Chemotherapy With Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases- Randomized Phase III Study |
| Lead sponsor | Arbeitsgruppe Lebermetastasen und Tumoren, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Liver Metastases |
| Intervention type | Drug |
| Interventions | Capecitabine, Oxaliplatin |
| Enrollment | 384 |
| Start date | Nov 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 25, 2009 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: